Plain-English translation of NCT06679244 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests a newer surgical technique called Hao's Esophagogastrostomy by Fissure Technique (HEFT) in patients undergoing surgery to remove upper stomach cancer. HEFT is designed to reduce acid reflux after surgery while preserving normal stomach function. The study compares this new technique to a standard surgical method called double-tract reconstruction to see which one helps patients maintain better nutrition and have fewer problems after surgery.
After removing the upper portion of the stomach for cancer, surgeons must reconnect the remaining stomach to the esophagus. Currently, there is no universally agreed-upon best way to do this. This trial exists to determine whether the newer HEFT technique produces better outcomes—including less weight loss, less acid reflux, and better overall quality of life—compared to the standard method.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you will be randomly assigned to receive either the new HEFT surgical technique or the standard double-tract reconstruction method. Both surgeries will be performed using minimally invasive laparoscopic techniques. After surgery, you will be followed up for one year, during which doctors will monitor your weight, nutrition status, any reflux symptoms, and overall recovery. The study plans to enroll patients over 2 years, with follow-up care continuing for an additional year after the final patient joins.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China